Method for treating huntington's disease using glial cell...

Details Method for treating huntington's disease using glial cell... Method for treating huntington's disease using glial cell...

A - Human Necessities

61

K

A61K 38/18 (2006.01) A61K 31/70 (2006.01) A61K 35/12 (2006.01) A61K 47/48 (2006.01) A61K 48/00 (2006.01)

Patent

CA 2220914

Methods are provided for preventing or reducing N-methyl-D-aspartate (NMDA) receptor agonist-mediated neuronal cell death by administering a glial cell line-derived neurotrophic factor (GDNF) protein product.

Invention d'une méthode qui permet de prévenir ou de réduire la dégénérescence neuronale induite par des agonistes des récepteurs de N-méthyl-D-aspartate (NMDA) consistant à administrer un produit protéique à base de GDNF.

Affiliated with

Also associated with

Rating

Method for treating huntington's disease using glial cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating huntington's disease using glial cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating huntington's disease using glial cell... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2012303